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PTPN21 and Hook3 relieve KIF1C autoinhibition
and activate intracellular transport
Nida Siddiqui 1,2,5, Alexander James Zwetsloot 1,3,5, Alice Bachmann1,2, Daniel Roth 1,2,
Hamdi Hussain 1,2, Jonathan Brandt 1,2, Irina Kaverina4 & Anne Straube 1,2
The kinesin-3 KIF1C is a fast organelle transporter implicated in the transport of dense core
vesicles in neurons and the delivery of integrins to cell adhesions. Here we report the
mechanisms of autoinhibition and release that control the activity of KIF1C. We show that the
microtubule binding surface of KIF1C motor domain interacts with its stalk and that these
autoinhibitory interactions are released upon binding of protein tyrosine phosphatase
PTPN21. The FERM domain of PTPN21 stimulates dense core vesicle transport in primary
hippocampal neurons and rescues integrin trafﬁcking in KIF1C-depleted cells. In vitro, human
full-length KIF1C is a processive, plus-end directed motor. Its landing rate onto microtubules
increases in the presence of either PTPN21 FERM domain or the cargo adapter Hook3 that
binds the same region of KIF1C tail. This autoinhibition release mechanism allows cargo-
activated transport and might enable motors to participate in bidirectional cargo transport
without undertaking a tug-of-war.
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Intracellular transport is essential for cell polarity and function.Long-distance transport of cellular cargo is mediated bymicrotubule-based motors, dynein and kinesin. While dynein
is the main transporter towards the minus end of microtubules,
most kinesins walk towards the microtubule plus end1. However,
many cargoes carry motors of both directionality in order to
allow directional switching when they encounter a roadblock
and the relative activity of the opposite directionality motors
determines the net progress of the cargo towards the cell per-
iphery (where usually most plus ends are located) or towards the
cell centre (where microtubule minus ends are abundant)1,2. We
have previously identiﬁed the kinesin-3 KIF1C as the motor
responsible for the transport of α5β1-integrins. The delivery of
integrins into cellular processes such as the tails of migrating cells
allows the maturation of focal adhesion sites3. KIF1C is also
required for the formation and microtubule-induced turnover
of podosomes—protrusive actin-based adhesion structures—in
both macrophages and vascular smooth muscle cells4–6. More-
over, KIF1C contributes to MHC class II antigen presentation,
Golgi organisation and transport of Rab6-positive secretory
vesicles7,8. In neurons, KIF1C transports dense-core vesicles both
into axons and dendrites and appears to be the fastest human
cargo transporter9,10. Consistently, human patients with missense
mutations in KIF1C resulting in the absence of the protein suffer
from spastic paraplegia and cerebellar dysfunction11. Mutations
that result in reduced motor function also cause a form of her-
editary spastic paraplegia12.
KIF1C-dependent cargo moves bidirectionally even in highly
polarised microtubule networks and depletion of KIF1C results
in the reduction of transport in both directions3, suggesting
that KIF1C cooperates with dynein as had been suggested for
other kinesin-3 motors13. To begin to unravel how KIF1C con-
tributes to bidirectional cargo transport, we need to identify
the mechanisms that switch KIF1C transport on and off.
Most kinesin-3 motors are thought to be activated by a
monomer–dimer switch, whereby cargo binding releases inhibi-
tory intramolecular interactions of neck and stalk regions by
facilitating the dimerisation of the neck coil and other coiled-coils
regions in the tail14–17. The motor thereby transitions from an
inactive, diffusive monomer to a processive dimer. In the alter-
native tail-block model, the motors are stable dimers, but regions
of the tail interact with the motor or neck domains and interfere
with motor activity until cargo binding occupies the tail region
and releases the motor18–20.
Here we show that KIF1C is a stable dimer that is autoinhibited
by intramolecular interactions of the stalk domain with the
microtubule binding interface of the motor domain. We
demonstrate that protein tyrosine phosphatase N21 (PTPN21)
activates KIF1C by binding to the stalk region. This function
does not require catalytic activity of the phosphatase, and its
N-terminal FERM domain alone is sufﬁcient to stimulate the
transport of KIF1C cargoes in cells as well as increasing the
landing rate of KIF1C on microtubules in vitro. The cargo
adapter Hook3 binds KIF1C in the same region and activates
KIF1C in a similar way, suggesting that both cargo binding and
regulatory proteins might contribute to the directional switching
of KIF1C–dynein transport complexes.
Results
KIF1C is an autoinhibited dimer. To determine the mechanism
of KIF1C regulation, we ﬁrst aimed to determine its mode of
autoinhibition. The monomer–dimer-switch and tail-block
models can be distinguished by determining the oligomeric
state of the motor. Thus we performed classic hydrodynamic
analysis using glycerol gradients and size exclusion chromato-
graphy on both puriﬁed recombinant full-length human KIF1C-
GFP from insect cells and KIF1C-Flag in human cell lysate
(Fig. 1a–c, Supplementary Fig. 1). The sedimentation coefﬁcient
and Stokes radius were determined in comparison to standard
proteins. We ﬁnd that the apparent molecular weight determined
both at physiological levels of salt (150 mM) and in high
(500 mM) salt buffer is consistent with KIF1C being a dimer
(KIF1C-GFP: apparent MW= 272 ± 57 kDa, expected dimer
MW= 308 kDa; KIF1C-Flag: apparent MW= 178 ± 45 kDa,
expected dimer MW= 251 kDa, all errors are SEM based on
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Fig. 1 KIF1C is a dimer. a Fractions from glycerol gradients of KIF1C-GFP at different salt concentrations as indicated. Elution peaks of standard proteins are
indicated with orange arrowheads. GOx, glucose oxidase. Errors are SEM. Uncropped gels are provided in Source Data ﬁle. b Size exclusion
chromatography of KIF1C-GFP at 150mM NaCl (grey) and 500mM NaCl (orange). Elution peaks of standard proteins (Tg thyroglobulin, Af apoferritin, Cat
catalase, BSA bovine serum albumin) and void volume V0 are indicated by orange arrowheads. Errors are SEM. c Frictional coefﬁcient of KIF1C-GFP at
different salt concentrations indicating that KIF1C elongates with increasing ionic strength. d, e Bleach curve of KIF1C-GFP on microtubules showing
discrete steps in ﬂuorescent decay in d. Experimentally determined bleach steps are shown in e together with best ﬁt to a mixed binomial model of dimers
and tetramers with x being the fraction of tetramer and p the fraction of active GFP molecules. n=108 motors. Data are provided in Source Data ﬁle
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errors of calibration curve ﬁt parameters and estimated precision
of peak location as 1/2 of fraction size). Consistent with this, the
majority of KIF1C-GFP molecules bound to microtubules in the
presence of non-hydrolysable AMPPNP show two bleach steps
and the distribution of bleach steps found ﬁts best to a simulation
of 88% dimers and 12% tetramers (Fig. 1d, e), assuming that
about 80% of GFPs are active, which is realistic based on previous
ﬁndings21. Interestingly, KIF1C elongates at increasing salt con-
centrations from a moderately elongated conformation (frictional
coefﬁcient of 1.5) at physiological salt to highly elongated (fric-
tional coefﬁcient= 1.9) at 500 mM (Fig. 1c), suggesting that
intramolecular electrostatic interactions might hold the KIF1C
dimer in a folded, autoinhibited state.
To determine the interaction surfaces involved in a possible
autoinhibited state, we performed crosslink mass spectrometry.
Puriﬁed KIF1C was treated with the 11 Å crosslinker BS3 or with
the zero length crosslinker EDC, digested with trypsin and then
subjected to tandem mass spectrometry analysis. Crosslinked
peptides were identiﬁed using StavroX22. Only crosslinked
peptides whose identity could be veriﬁed by extensive fragmenta-
tion with none or few unexplained major peaks were retained
(Supplementary Figs. 2 and 3). These high-conﬁdence crosslinks
were between K273-K591, K273-K645, K464-K645, K640-K645,
K464-E606 and E644-K854 (Fig. 2a, Supplementary Figs. 2 and 3),
showing that the end of the FHA domain and the third coiled-coil
contact the motor domain near K273. This residue is within
alpha-helix 4 at the centre of the microtubule interaction interface
of the motor domain23 (Fig. 2b). In the presence of 500 mM
NaCl, the abundance of the stalk-to-motor domain crosslinks
was dramatically reduced consistent with the observed elongation
of KIF1C dimer in glycerol gradients (Supplementary Figs. 2e
and 1c). These ﬁndings suggest that KIF1C adopts a more
e
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Fig. 2 KIF1C is autoinhibited by intramolecular interactions of stalk and motor domain. a Schematic primary structure of KIF1C with motor domain (blue),
coiled-coil domains (green), FHA domain (yellow), and Proline-rich domain (orange). Crosslinks identiﬁed using mass spectrometry after treatment with
BS3 or EDC are shown as magenta loops. Published binding sites for KIF1C interactors are indicated below. See Figs. S2 and S3 for ion fragmentation of
crosslinked peptides. b Motor domain of related KIF1A on tubulin. The region in the motor domain that interacts with KIF1C stalk is indicated by magenta
stars. c Hypothetical model of autoinhibited KIF1C conformation based on identiﬁed crosslinks. d Coomassie-stained SDS-PAGE gel of puriﬁed KIF1C motor
domain, stalk domain and GST control. e Schematic primary structure of KIF1C motor and stalk proteins used here. f Binding afﬁnity measurements and Kd
model ﬁts from three microscale thermophoresis experiments probing the interaction of KIF1C motor domain with the stalk domain. g Representative TIRF
images showing microtubule decoration of KIF1C motor domain in the presence of GST (control) and KIF1C tail domain. Scale bar 5 µm. Linescans of one of
the microtubules from each ﬁeld is shown below. h Quantiﬁcation of mean intensity of KIF1C motor domain on microtubules. Distribution is shown together
with mean and full extent of data. n= 690 and 659 microtubules, respectively, pooled from six experiments. *** indicates p= 10−99 (t-test)
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10644-9 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2693 | https://doi.org/10.1038/s41467-019-10644-9 | www.nature.com/naturecommunications 3
compact conformation in physiological conditions whereby the
stalk domain blocks the motor domain from interacting with
microtubules (Fig. 2c). To conﬁrm this intramolecular interaction
and the autoinhibition directly, we puriﬁed bacterially expressed
KIF1C motor domain and KIF1C stalk domains (Fig. 2d, e).
Using microscale thermophoresis, we measured the afﬁnity of
motor and stalk domains as 1 µM (Fig. 2f). Consistent with the
idea that the stalk competes with microtubule binding, we found
that microtubule decoration by the KIF1C motor domain was
signiﬁcantly reduced in the presence of 1 µM stalk domain,
but not when 1 µM GST was added as control (Fig. 2g, h). Thus
KIF1C is a stable dimer that blocks its microtubule-binding
interface with an intramolecular interaction in its autoinhibited
conformation.
PTPN21 stimulates transport of KIF1C cargoes. We next aimed
to identify a regulator that could engage with the stalk domain
and thereby activate the motor. Two proteins had previously been
shown to interact with the KIF1C stalk domain, non-muscle
Myosin IIA4 and protein tyrosine phosphatase N21 (PTPN21,
also known as PTPD1)24 (Fig. 2a). We reasoned that a KIF1C
activator would be required for KIF1C function in cells and thus
would phenocopy KIF1C depletion. As a readout of diminished
KIF1C activity, we used the reduced podosome number in vas-
cular smooth muscle cells that we reported previously5. Myosin
IIA inhibition did not phenocopy KIF1C depletion. Instead,
inhibition of Myosin IIA with Blebbistatin or indirectly via
inhibition of Rho kinase using Y27632 did not result in reduced
podosome number, while remaining actin stress ﬁbres were efﬁ-
ciently removed (Fig. 3a–d). As depletion of Myosin IIA did also
have opposite effects on the stability of cell tails and directional
persistence of cell migration we previously reported for KIF1C
depletion3, we excluded Myosin IIA as being involved in KIF1C
activation. In contrast, PTPN21 depletion using siRNA resulted
in a dramatic reduction of podosome number (Fig. 3e–h). To
conﬁrm speciﬁcity of the RNAi we rescued the phenotype with
HA-tagged PTPN21. Interestingly, the catalytically inactive
mutant PTPN21C1108S (ref. 25) could also fully rescue the PTPN21
depletion phenotype (Fig. 3e, f), suggesting that a scaffold func-
tion is required rather than phosphatase activity.
Strikingly, expression of PTPN21C1108S also efﬁciently com-
pensated for partial depletion of KIF1C and fully rescued
podosome formation (Fig. 4a–c). An N-terminal 378 amino acid
fragment of PTPN21, which contains a FERM domain, was
previously shown to be sufﬁcient to interact with KIF1C24.
Therefore we tested this construct, and found that the PTPN21
FERM domain alone was sufﬁcient to rescue the KIF1C depletion
phenotype (Fig. 4a–c). This suggests that PTPN21 scaffolding
could activate the remaining pool of KIF1C, which is reduced
to about 25–30% in cells treated with siKIF1C-2 compared to
control cells3,5. Alternatively, PTPN21 could also activate another
kinesin to compensate for KIF1C depletion. KIF16B, another
kinesin-3, was an obvious candidate for this as its interaction with
PTPN21 FERM domain had been shown already26. To
discriminate between these two possibilities, we depleted KIF1C
and KIF16B individually and simultaneously in PTPN21 FERM
rescue experiments. KIF16B depletion on its own resulted only in
a mild reduction in podosome numbers and expression of FERM
domain signiﬁcantly increased the number of podosomes formed
in control cells and in those where either of the kinesins was
depleted. However, PTPN21 FERM did not increase podosome
numbers in cells that were depleted for both KIF1C and KIF16B
(Fig. 4d, Supplementary Fig. 4). These ﬁndings suggest that
PTPN21 rescue depends on the presence of a sizeable pool of
either KIF1C or KIF16B. To explore this activity further, we
investigated more directly whether PTPN21 stimulates KIF1C-
dependent transport processes. We have shown previously that
KIF1C is required for the bidirectional transport of integrin-
containing vesicles in migrating RPE1 cells3. The depletion of
KIF1C results in a reduction of both plus-end and minus-end-
directed transport and an increase in stationary vesicles.
Expression of either wild-type PTPN21, the catalytically inactive
PTPN21C1108S mutant or PTPN21FERM reactivated integrin
vesicle transport in KIF1C-depleted cells (Fig. 4e, f). To test
whether the ability of PTPN21FERM to activate KIF1C-dependent
transport universally applies, we next isolated primary hippo-
campal neurons and observed the transport of dense-core vesicles
labelled with NPY-RFP in the presence of either a control plasmid
or pFERM. Consistent with a function to activate KIF1C-
dependent transport, we observed a dramatically increased
frequency of vesicles moving in anterograde direction through
the neurites in cells expressing the FERM domain of PTPN21
(Fig. 4g–i).
PTPN21 relieves KIF1C autoinhibition. Our experiments in
cells identiﬁed PTPN21 as a potential activator of KIF1C. To
conﬁrm that the PTPN21 FERM domain can directly activate
KIF1C, and to further interrogate the mechanism of activation,
we reconstituted KIF1C motility in vitro. Hilyte647- and biotin-
labelled microtubules were assembled in the presence of GTP,
then stabilised with Taxol and attached to a PLL-PEG-biotin-
coated coverslip. Six hundred picomolar KIF1C was added in
the presence of 1 mM ATP and an ATP-regenerating system. At
25 °C, individual KIF1C-GFP dimers moved processively
towards the plus end of the microtubule where they accumulated
(Fig. 5a). The average speed and run length were 0.45 µm/s and
8.6 µm respectively (Fig. 5d). We then puriﬁed recombinant
PTPN21FERM-6His and for comparison EzrinFERM-6His from
Escherichia coli (Fig. 5c). Consistent with being an activator, the
landing rate of KIF1C motors increased by about 40% in the
presence of PTPN21FERM (Fig. 5b–d). The frequency of observing
running motors was also increased by 40%. EzrinFERM, acting as a
negative control, did not signiﬁcantly affect the landing rate or
the frequency of running motors (Fig. 5b–d). These ﬁndings are
consistent with the idea that PTPN21 opens the KIF1C motor by
binding to its tail domain and thereby relieves autoinhibition
and increases the binding rate of the motor.
If PTPN21 relieves the autoinhibition, the following two
predictions should hold true: (i) PTPN21FERM binding should
remove the interactions between stalk and motor domain of
KIF1C and (ii) deleting the region required for autoinhibition
should result in a dominant-active motor that cannot be further
activated by binding of PTPN21FERM. To test the ﬁrst prediction,
we performed crosslinking mass spectrometry experiments with
KIF1C and PTPN21FERM. We found two new crosslinks, but
could no longer ﬁnd the intramolecular crosslinks in KIF1C
(Fig. 5e, f). The new crosslinks show interactions of the FERM
domain with lysines 591 and 645 in KIF1C (Supplementary
Fig. 5). Because the crosslinks between motor domain and stalk
were absent in the presence of PTPN21FERM, the relative
abundance of the un-crosslinked LKEGANINK peptide at the
microtubule binding interface of KIF1C increased more than
twofold in the KIF1C+ PTPN21FERM sample compared to KIF1C
alone (Fig. 5e). These data conﬁrm that the presence of the FERM
domain is capable of freeing the motor domain, and relieving
the autoinhibition of KIF1C. To test the second prediction,
we generated two deletion mutants, KIF1CΔCC3 in which we
removed coiled-coil 3, which makes the predominant contact
with the motor domain in the autoinhibited conformation and
KIF1CΔS where we removed coiled-coil 3 and the stalk region
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previously identiﬁed as minimal PTPN21-binding domain
(Fig. 6a). First, we assessed whether either or both constructs
are hyperactive by localisation of the construct in cells. We had
described previously that KIF1C accumulates speciﬁcally in tails
of migrating RPE1 cells3. Expression of KIF1CΔCC3-GFP and
KIF1CΔS-GFP in RPE1 cells resulted in accumulation of the
construct in cell tails and also elsewhere at the periphery of the
cell (Fig. 6b). As tail accumulation is sensitive to tail state, i.e.
whether it is forming or retracting3, we used KIF1C-mCherry as
an internal control. In comparison to KIF1C-GFP, which was
enriched in tails to a similar extent as KIF1C-mCherry (tail:
cytoplasm ratio 6.1 ± 1.3 for KIF1C-mCherry and 7.4 ± 1.2 for
KIF1C-GFP, n= 26 cells, errors are SEM), KIF1CΔCC3-GFP was
almost threefold more enriched (tail:cytoplasm ratio 3.9 ± 0.6
for KIF1C-mCherry and 13.6 ± 2.1 for KIF1CΔCC3-GFP, n= 32
cells), and KIF1CΔS-GFP was fourfold more enriched (tail:
cytoplasm ratio 1.8 ± 0.3 for KIF1C-mCherry and 7.7 ± 0.8
for KIF1CΔS-GFP, n= 39 cells) (Fig. 6c). Secondly, we
puriﬁed recombinant KIF1CΔCC3-GFP and KIF1CΔS-GFP from
insect cells (Fig. 6d) and performed single-molecule assays.
KIF1CΔCC3-GFP had a threefold higher landing rate compared
to wild-type KIF1C-GFP, and addition of PTPN21FERM did
not further increase the landing rate of KIF1CΔCC3-GFP
(Fig. 6e–g, k). KIF1CΔS-GFP had a 20-fold higher landing rate
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than KIF1C-GFP and also moved at about threefold higher
average speed (Fig. 6h–m). Therefore, these experiments conﬁrm
that binding of PTPN21 to the stalk domain of KIF1C relieves the
autoinhibition of KIF1C and thereby enables the motor to engage
with microtubules.
Hook3 binds to KIF1C stalk and also activates KIF1C. Finally,
we wondered how universal this mechanism is and whether other
proteins binding KIF1C stalk could activate KIF1C in a similar
manner. To identify KIF1C stalk interactors we performed a
BioID experiment with full-length KIF1C and KIF1CΔS (Fig. 7a).
We identiﬁed 43 proteins or clusters of proteins isolated with
streptavidin-beads upon biotinylation that were signiﬁcantly
enriched in either the KIF1C-BioID2 or KIF1CΔS-BioID2 sam-
ples. Eight of those were enriched more than 10-fold in the full-
length sample. The most signiﬁcant hit was Hook3 (Fig. 7b)
which was 50-fold enriched in the full-length sample and thus
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appeared as a possible KIF1C stalk interactor. We conﬁrmed that
both Hook3 and PTPN21 bind to KIF1C in a stalk-dependent
manner using co-immunoprecipitation from HEK293 cells
(Fig. 7c, Supplementary Fig. 6). Hook3 has previously been
identiﬁed as an activator of dynein/dynactin—an activity
requiring its N-terminal globular domain and all three coiled-coil
domains27–30. In contrast, the C-terminus of Hook3 was shown
to interact with KIF1C31. To test whether Hook3 could also
activate KIF1C, we puriﬁed recombinant human Hook3 with a C-
terminal SNAP-tag from insect cells (Fig. 7d), labelled it with
Alexa647 and performed single-molecule assays with KIF1C.
In the presence of Hook3, the landing rate of KIF1C increased
twofold (Fig. 7e, f), thus conﬁrming that Hook3 functions as
an activator similarly to PTPN21 by binding to the KIF1C stalk
region adjacent to the site engaged in intramolecular interactions
of KIF1C during autoinhibition. As we could observe that Hook3
was co-transported with KIF1C (Fig. 7e), we asked whether
PTPN21 also maintained contact with KIF1C after activating it.
We puriﬁed and labelled FERM-SNAPf with Alexa647 similarly
to our Hook3 construct and performed two-colour TIRF assays
both with KIF1C-GFP and KIF1CΔS-GFP. Both activators were
co-transported with full-length KIF1C, but not with KIF1CΔS
(Fig. 8a–d). This suggests that both PTPN21 and Hook3 act as
scaffolds to activate KIF1C by engaging with its stalk region
(Fig. 8e, f).
Discussion
Our ﬁndings support a model whereby KIF1C is a stable dimer
that is held in an autoinhibited conformation by interaction of
its stalk region including the third coiled-coil domain with the
microtubule binding surface of the motor domain (Fig. 8e).
Autoinhibition is relieved upon binding of PTPN21 FERM
domain or Hook3, allowing the motor domain to engage with
microtubules (Fig. 8f). While the model agrees with the ﬁnding
that KIF1C motors are dimeric in cells32, this is in contrast to
the mode of autoinhibition described for other kinesin-3 motors,
KIF1A, Unc104, KIF16B, KIF13A and KIF13B that all undergo a
monomer–dimer transition14–17. However, interactions of the
stalk or tail region with the motor domain have also been
described for KIF13B and KIF16B19,20. These might act as a
second layer of activity control once dimers are formed or sta-
bilise the inhibited monomer conformation. Our data suggest that
KIF1C autoinhibition acts by steric blockage of the microtubule
binding. In contrast, kinesin-1, which is also autoregulated by a
tail-block mechanism, is inhibited by crosslinking of the motor
domains that prevent movement required for neck linker
undocking33,34.
We identify the phosphatase PTPN21 as a KIF1C activator.
The ﬁrst 378 amino acids containing the FERM domain are
sufﬁcient to activate KIF1C in vitro and in cells and does neither
require the catalytic activity nor the phosphatase domain of
PTPN21. Even though a scaffold activity is sufﬁcient, it is still
possible that PTPN21-mediated dephosphorylation of KIF1C24
can further modulate the activity of KIF1C, modify KIF1C cargo,
cargo adapters or the activity of adjacent motors, a possibility
that will be interesting to explore in a future study. PTPN21
has been shown to dynamically localise to focal adhesions35
or EGF receptor recycling sites36. It is possible that KIF1C-
mediated transport facilitates the efﬁcient turnover of PTPN21
at these sites. Thus the phosphatase could be both a cargo and
a regulator of KIF1C. We have implicated KIF1C previously in
the transport of integrins required for the maturation of
trailing focal adhesions3. It is possible that additionally, KIF1C
transport facilitates PTPN21-mediated regulation of Src tyrosine
kinase and FAK signalling that promote cell adhesion and
migration35.
PTPN21 FERM was able to compensate for depletion of KIF1C
by activating KIF16B, a highly processive early endosome trans-
porter that has been shown to also interact with PTPN21
FERM15,26,37. The expression of the FERM domain efﬁciently
stimulated dense-core vesicle transport in primary neurons.
PTPN21 has been associated with schizophrenia in a genome-
wide association study38 and shown to promote neuronal survival
and growth39,40. While the latter is thought to occur via NRG3 or
ERK1/2 signalling, neuronal function and morphology is com-
promised when microtubule transport is perturbed and the
function of PTPN21 as neuronal transport regulator might con-
tribute to the complications in schizophrenia patients with
PTPN21 mutations. Further, cAMP/PKA pathway stimulation of
kinesin-1 has been shown to reverse aging defects in Drosophila
neurons, and a similar age-driven decrease in KIF1C transport
of dense-core vesicles and other organelles may have similar
effects in neurodegenerative diseases41.
The ﬁndings that Hook3 can activate both dynein/
dynactin27,29,30 and KIF1C (this study), and that the binding sites
for these opposite directionality motors are non-overlapping29,31,
suggests that Hook3 could simultaneously bind to KIF1C and
dynein/dynactin and provide a scaffold for bidirectional cargo
transport. Evidence for the existence of a complex of dynein/
dynactin, KIF1C and Hook3 has recently been provided in a
preprinted manuscript42. We note that this study did not report
an activation of KIF1C upon binding of Hook3; however, this is
based solely on the analysis of speed and run lengths, while we
ﬁnd that activation primarily increases KIF1C landing rates. How
the directional switching would be orchestrated in such a KIF1C-
DDH complex is an exciting question for the future. It is
important to note that Hook3 is not the only dynein cargo
adapter which binds KIF1C. BICDR1 has been shown to bind to
the proline-rich C-terminal region of KIF1C9, and BICD2
Fig. 4 PTPN21 activates intracellular transport. a Primary structure of PTPN21 and N-terminal fragment used in this study. The region identiﬁed to
interact with kinesins, actin and Src kinase is indicated below. b, c A7r5 cells treated with 5 µM PDBu for 1 h and stained for cortactin as a marker
for podosomes. Expression of catalytically inactive PTPN21 or just the FERM domain rescues the podosome formation phenotype of KIF1C-depleted
cells. n= 60 cells. ***p < 0.0001 (Mann–Whitney U-test with Bonferroni). Scale bar 20 µm. Data are provided in Source Data ﬁle. d Podosome formation
in A7r5 cells treated with siKIF1C, siKIF16B or both. Expression of the FERM domain increases podosome formation unless both kinesins are depleted.
n= 90 cells pooled from three independent experiments. ***p < 0.0001 **p < 0.001 (Mann–Whitney U-test with Bonferroni). See Supplementary Fig. 4
for representative examples. Data are provided in Source Data ﬁle. e, f Kymographs of α5-integrin vesicles in the tail of migrating RPE1 cells. KIF1C
depletion results in increase of vesicles moving less than 1.5 µm. Expression of various PTPN21 constructs suppresses the KIF1C depletion phenotype.
n= 36–158 cells pooled from 3 to 11 independent experiments. ***p < 0.0001 and n.s. p > 0.5 (ANOVA+ Tukey post hoc relative to siControl). Data
are provided in Source Data ﬁle. g–i Representative kymographs show primary hippocampal neurons isolated from a P2 mouse, transfected with NPY-RFP
and either pFlag (as control) or pFERM. Number of NPY-positive vesicles passing a location per minute and the average speed of vesicles is shown
for anterograde and retrograde movement. Data pooled from three independent experiments (DIV5-6). n= 3760 neurites/197,953,136,480 vesicles.
***p < 0.0001; **p < 0.005; n.s.p > 0.5 (Kolmogorov–Smirnov)
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appears to interact with KIF1C biochemically43. Whether
BICDR1 or BICD2 are able to activate the motor is unclear, but it
is possible that different adapters not only mediate linkage to a
different set of cargoes, but also recruit opposite polarity motors
in different conformations and thus relative activity. For dynein/
dynactin, such a difference is seen in BICD2 recruiting only one
pair of dynein heavy chains while BICDR1 and Hook3 recruit two
pairs and thus are able to exert higher forces28. BICDR1 also
binds Rab6 and recruits both dynein/dynactin and KIF1C
to participate in the transport of secretory vesicles9. Rab6 in turn
has been shown to bind and inhibit the KIF1C motor domain7.
This could provide a potential mechanism for a second layer of
regulatory control of KIF1C activity to facilitate its minus end-
directed transport with dynein-dynactin-Hook3.
Taken together, we provide mechanistic insight into the reg-
ulation of KIF1C, a fast long-distance neuronal transporter. We
show that KIF1C is activated by a scaffold function of PTPN21
and the dynein cargo adapter Hook3, but the mechanism of
autoinhibition release described here is likely to be universal and
we expect cargoes and further scaffold proteins binding to the
stalk region around the third coiled-coil in KIF1C to also activate
the motor and initiate transport along microtubules. This opens
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Fig. 5 PTPN21 FERM domain activates KIF1C in vitro. a KIF1C-GFP (green) is a processive motor in single-molecule assays on Taxol-stabilised microtubules
(magenta). Scale bar 2 µm. b Representative kymographs from single-molecule experiments of KIF1C in the presence of FERM domains of PTPN21 and
Ezrin. Grey lines indicate immobile motors; green lines running motors and orange dots landing events. c Coomassie-stained SDS-PAGE of puriﬁed KIF1C-
GFP and FERM domains of PTPN21 and Ezrin. d Quantiﬁcation of landing rate, frequency of running motors (>25 nm/s), average velocity and run length.
n= 30, 39 and 21 microtubules respectively from three independent experiments. *p < 0.05, **p < 0.005, ***p < 0.0005, n.s. p > 0.05 (t-test with
Bonferroni correction). Data are provided in Source Data ﬁle. e, f Crosslinking mass spectrometry of KIF1C in the presence of PTPN21-FERM identiﬁed two
crosslinks between KIF1C and the FERM domain. Crosslinks in KIF1C alone are shown for comparison. Star indicates peptide in motor domain that is found
in crosslinks with stalk domain (labelled 1 and 2). Relative abundance of single peptide LKEGANINK (star) and the two crosslinked peptides between motor
and stalk domain are shown for KIF1C alone and KIF1C+ PTPN21-FERM. Data show mean ± SD for three independent experiments. See Supplementary
Figs. 2, 3 and 5 for ion fragmentation spectra. Data are provided in Source Data ﬁle
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up new research avenues into how KIF1C activity is controlled
in space and time in cells.
Methods
Plasmids and siRNAs. The following plasmids used in this study were described
previously: pKIF1CRIP2GFP (ref. 5), pKIF1C-mCherry, pKIF1C-2xFlag, pFlag3,
pα5-integrin-GFP44, pNPY-RFP45, pHA-PTPN21-WT and pHA-PTPN21-
C1108S (ref. 25).
pFastBac-M13-6His-KIF1CGFP was generated by digesting pKIF1CRIP2GFP
with EcoRI–MfeI and replacing it in the backbone of pFastBac-M13 (Invitrogen).
A resulting frameshift between the 6His tag and the N-terminus of KIF1C was
corrected by cutting with EcoRI, mung bean nuclease treatment and religation
of the vector.
KIF1CΔCC3 (i.e. KIF1CΔ623–679) and KIF1CΔS (i.e. KIF1CΔ623–825)
deletions were generated by PCR, introducing SalI restriction sites after amino
acid position D679 using oligo AS370 and after amino acid position D825 using
AS371 with AS83 as the reverse primer (see Supplementary Table 1 for sequences
of DNA oligonucleotides used in this study). The SalI–BamHI fragment in
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Fig. 6 Deletion of KIF1C stalk results in a hyperactive motor. a Primary structure of hyperactive KIF1C deletion mutants used here. b Representative
RPE1 cells co-transfected with full-length KIF1C-mCherry and either KIF1C-GFP, KIF1CΔCC3-GFP or KIF1CΔS-GFP and imaged 36 h post transfection. Scale
bar is 20 µm. c Box plot shows ratio of KIF1C enrichment at the tail relative to cytoplasmic levels for GFP vs. mCherry channel. ***p < 0.0005
(Kolmogorov–Smirnov). n= 26, 32, 39 cells. Data are provided in Source Data ﬁle. d Coomassie-stained SDS-PAGE of puriﬁed KIF1C-GFP and deletion
mutants. e–i Representative kymographs from single-molecule experiments. Grey lines indicate immobile motors, green lines running motors and orange
dots landing events. j, k Frequency of KIF1C landing events and average velocity of running motors (>25 nm/s). n= 17, 82, 58, 22, 24 microtubules,
respectively, pooled from three experiments. ***p < 0.0005 (t-test with Bonferroni correction). Data are provided in Source Data ﬁle
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pKIF1CRIP2GFP was replaced with the truncated fragments to create plasmids
pKIF1CRIP2ΔCC3-GFP and pKIF1CRIP2ΔS-GFP for mammalian expression.
pFastBac-M13-6His-KIF1CΔCC3-GFP and pFastBac-M13-6His-KIF1CΔS-GFP
were generated by digesting pKIF1CRIP2ΔCC3-GFP and pKIF1CRIP2ΔS-GFP with
BsiWI-BamHI and replacing KIF1C in pFastBac-M13-6His-KIF1CGFP. A human
codon-optimised BioID2-HA construct46 was synthesised to include 5′ BamHI and
3′ NotI restriction sites allowing direct substitution of the C-terminal GFP of
pKIF1CRIP2GFP and pKIF1CRIP2ΔS-GFP with a BioID2-HA tag to generate
pKIF1CRIP2-BioID2-HA and pKIF1CRIP2ΔS-BioID2-HA.
The motor-GFP construct (pET22b-KIF1C(1–349)-NTVSVN-GFP-6H) was
generated by amplifying the ﬁrst 349 amino acids of KIF1C using primers UT157
and AS813, digesting with NdeI and NcoI and replacing EB1 in pET22b-mEB1-
GFP-6His47. The KIF1C stalk construct was cloned into a modiﬁed pGEX-6P2
vector (pGEX-6P2-LTLT) which contains an insertion of a tandem TEV cleavage
site between the BamHI and EcoRI sites. Amino acids 612 to 922 from human
KIF1C were ampliﬁed from pKIF1C-2xFlag using AS696 and AS778, digested with
EcoRI and NotI, and ligated into pGEX-6P2-LTLT to create pGEX-6P2-LTLT-
KIF1C(612–922).
RNAi-protected PTPN21 was made using pHA-PTPN21-WT as a template in a
three-step mutagenesis PCR using AS397, AS380 and AS264. The fragment
containing the mutation was replaced in pHA-PTPN21-WT using NheI to generate
pHA-PTPN21RIP. RNAi-protected inactive PTPN21, pHA-PTPN21RIPC1108S was
generated by replacing the fragment containing mutation C1108S in pHA-
PTPN21RIP using BsgI.
pFERM expressing HA-tagged PTPN211–377 was generated by digesting pHA-
PTPN21RIP and pEGFP-N1 (Clontech) with HindIII and inserting the fragment in
pEGFP-N1. As the GFP is not in frame, the FERM domain is expressed from this
plasmid with an N-terminal HA-tag only.
To express and purify FERM domains from E. coli, pET22b-HA-PTPN211–381-
6His was generated by amplifying pHA-PTPN21RIP by PCR with primers AS558
and AS592, digesting with NdeI and NotI and replacing EB1 in pET22b-mEB1-
6His47. For labelling FERM domain, SNAPf-26 was codon optimised for E. coli,
synthesised, and ligated into a PCR cloning vector generating pCAPs-SNAPf-26
with the addition of 5′ and 3′ NdeI and KpnI sites. The HA tag in pET22b-HA-
PTPN211–381-6His was exchanged for SNAPf-26 in a three-fragment ligation where
the backbone was digested with PvuI and NdeI or PvuI and KpnI, and the SNAPf-
26 insert was digested with NdeI and KpnI.
FERM domain from Ezrin, pET22b-HA-Ezrin1–328-6His was generated by PCR
from random-primed cDNA reverse transcribed from RPE1 RNA using primers
AS556 and AS557, digesting with NdeI and NotI and replacing in pET22b-mEB1-6His.
Hook3 was cloned by PCR from random-primed cDNA reverse transcribed
from RPE1 RNA using primers AS690 and AS691, which was incorporated
between the EcoRI and BamHI site of pKIF1CRIP2GFP, replacing the KIF1C and
generating pKan-CMV-Hook3-GFP. A multi-tag version of pFastBacM13
(Invitrogen) was created by ligating an insect-cell codon optimised synthesised
cDNA for 8His-ZZ-LTLT-BICDR1-SNAPf between the RsrII and NotI sites
creating pFastBacM13-8His-ZZ-LTLT-BICDR1-SNAPf. Hook3 was cloned into this
by PCR from random-primed cDNA reverse transcribed from RPE1 RNA using
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primers AS689 and AS691 which allowed direct ligation into the multi-tag
pFastBacM13 vector creating pFastBacM13-8His-ZZ-LTLT-Hook3-SNAPf, which
was subsequently used for production of a recombinant baculovirus.
Duplex siRNA oligos targeting KIF1C, KIF16B and PTPN21 were custom
synthesised by Sigma and were: siControl 5′-GGACCUGGAGGUCUGCUGU-
[dT]-[dT]-3′ (ref. 3), siKIF1C-2 (targeting both rat and human KIF1C) 5′-GUGA
GCUAUAUGGAGAUCU-[dA]-[dT]-3′ (refs. 3,5), siPTPN21 (targeting both rat
and human PTPN21) 5′-UUCAGCCUCUGGUACUACA-[dT]-[dT]-3′, siKIF16B
(targeting rat KIF16B) 5′-GAACUACAGCGACGUGGAG-[dT]-[dT]-3′.
Recombinant protein puriﬁcation. For baculovirus expression, pFastBac-M13-
6His-KIF1CGFP, pFastBac-M13-6His-KIF1CΔCC3-GFP, pFastBac-M13-6His-
KIF1CΔS-GFP and pFastBacM13-8His-ZZ-LTLT-Hook3-SNAPf plasmids were
transformed into DH10BacYFP competent cells48 and plated on LB-Agar
supplemented with 30 µg/ml kanamycin (#K4000, Sigma), 7 µg/ml gentamycin
(#G1372, Sigma), 10 µg/ml tetracycline (#T3258, Sigma, 40 µg/ml Isopropyl β-D-1-
thiogalactopyranoside (IPTG, #MB1008, Melford) and 100 µg/ml X-Gal (#MB1001,
Melford). Positive transformants (white colonies) were screened by PCR using M13
forward and reverse primers for the integration into the viral genome. The bacmid
DNA was isolated from the positive transformants by the alkaline lysis method and
transfected into SF9 cells (Invitrogen) with Escort IV (#L-3287, Sigma) according
to the manufacturer’s protocols. After 5–7 days, the virus (passage 1, P1) is har-
vested by centrifugation at 300 × g for 5 min in a swing out 5804 S-4-72 rotor
(Eppendorf). Baculovirus infected insect cell (BIIC) stocks were made by infecting
SF9 cells with P1 virus and freezing cells before lysis (typically around 36 h) in a 1°
cooling rate rack (#NU200 Nalgene) at −80 °C. P1 virus was propagated to passage
2 (P2) by infecting 50 ml of SF9 (VWR, #EM71104-3) culture and harvesting after
5–7 days as described above49. For large-scale expression, 500 ml of SF9 cells at a
density of 1–1.5 × 106 cells/ml were infected with one vial of BIIC or P2 virus. Cells
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were harvested when 90% infection rate was achieved as observed by YFP ﬂuor-
escence, typically between 48 and 72 h. Cells were pelleted at 252 × g in a SLA-3000
rotor (Thermo Scientiﬁc) for 20 min. For puriﬁcation of recombinant KIF1C-GFP,
KIF1CΔCC3-GFP and KIF1CΔS-GFP, the pellet was resuspended in 4 ml of SF9
lysis buffer (50 mM Sodium phosphate pH 7.5, 150 mM NaCl, 20 mM Imidazole,
0.1% Tween 20, 1.5 mM MgCl2) per gram of cell pellet, supplemented with 0.1 mM
ATP and cOmplete protease inhibitor cocktail (#05056489001, Roche) and lysed
using a douncer (#885301, Kontes) with 20 strokes. Lysates were then cleared by
centrifugation at 38,000 × g in a SS-34 rotor (Sorvall) for 30 min, or 200,000 × g for
40 min in a T865 rotor (Sorvall). SP Sepharose beads (#17-0729-01, GE Healthcare)
were equilibrated with the lysis buffer and the cleared lysate obtained is mixed with
the beads and batch bound for 1 h. Next, the beads were loaded onto a 5 ml
disposable polypropylene gravity column (#29922, Thermo Scientiﬁc) and washed
with at least 10 CV SP wash buffer (50 mM sodium phosphate pH 7.5, 150 mM
NaCl) and eluted with SP elution buffer (50 mM sodium phosphate pH 7.5,
300 mM NaCl). The peak fractions obtained were pooled and diluted with Ni-NTA
lysis buffer (50 mM sodium phosphate pH 7.5, 150 mM NaCl, 20 mM Imidazole,
10% glycerol) and batch bound to Ni-NTA beads (#30230, Qiagen) for 1 h. The
beads were loaded onto a gravity column and washed with at least 10 CV of Ni-
NTA wash buffer (50 mM sodium phosphate pH 7.5, 150 mM NaCl, 50 mM
Imidazole and 10% glycerol) and eluted with Ni-NTA elution buffer (50 mM
sodium phosphate pH 7.5, 150 mM NaCl, 150 mM Imidazole, 0.1 mM ATP and
10% glycerol). The peak fractions were run on a SDS-PAGE gel for visualisation
and protein was aliquoted, ﬂash frozen and stored in liquid nitrogen.
Hook3-647 was puriﬁed and labelled in a two-step process utilising both the His
and ZZ afﬁnity tags at 4 °C. A pellet corresponding to 500 ml insect culture was
resuspended in 40 ml Adaptor Lysis Buffer (50 mM HEPES pH 7.2, 150 mM NaCl,
20 mM imidazole, 1× cOmplete protease inhibitor cocktail, 1 mM DTT) and lysed
with 20 strokes in a douncer. Lysates were cleared of insoluble material by
centrifugation at 50,000 × g for 40 min in a Sorvall T-865 rotor. The cleared lysate
was bound to 2 ml Ni-NTA beads for 2 h, and subsequently washed with 200 CV of
lysis buffer followed by 200 CV lysis buffer supplemented with 60 mM imidazole.
Protein was eluted in 5 CV of lysis buffer containing 350 mM Imidazole, and the
eluate was batch bound to 1 ml IgG Sepharose (#17-0969-01, GE Healthcare Life
Sciences) for 2 h. Beads were brieﬂy washed with TEV cleavage buffer (50 mM
Tris-HCl pH 7.4, 148 mM KAc, 2 mM MgAc, 1 mM EGTA, 10% (v/v) glycerol,
1 mM DTT) before being collected in a 1.5 ml Eppendorf tube and incubated with
3.5 µM SNAP-Surface Alexa Fluor 647 substrate (#S9136S, New England Biolabs)
for 2 h. Beads were washed with 200 CV TEV cleavage buffer and resuspended in a
1.5 ml Eppendorf tube containing 50 µg/ml TEV protease, which was allowed to
digest the protein off of beads overnight at 4 °C. Finally, eluate was collected from
the beads, concentrated to between 5 and 10 µM in a Centrisart I 20 kDa
ultraﬁltration device (#13249-E, Sartorius), ﬂash frozen and stored in liquid
nitrogen. Labelling ratio was 1.05 for Hook3-647.
Bacterial expression plasmids, pET22b-HA-PTPN211–381-6His and pET22b-
HA-Ezrin1–328-6His were transformed into BL21 DE3 (Invitrogen), pET22b-KIF1C
(1–349)-NTVSVN-GFP-6H, pET22b-SNAPf26-PTPN211–381-6His, pGEX-6P2 and
pGEX-6P2-LTLT-KIF1C(612–922) were transformed into BL21 CodonPlus RIL
(Agilent). Single colonies were grown overnight as 3 ml starter cultures. The starter
cultures were diluted 1:100 and grown in 200 ml of 2× YT (yeast extract, tryptone
16 g) at 37 °C, 180 r.p.m. until they reached an OD600nm of 0.5. Expression was
induced with 0.5 mM or 1 mM IPTG and incubated at 16 °C or 18 °C overnight.
For puriﬁcation of recombinant PTPN21-FERM, SNAPf26-PTPN21-FERM
and Ezrin-FERM, cells were harvested at 1500 × g in an SLA-3000 rotor and
resuspended in bacterial lysis buffer (50 mM sodium phosphate pH 7.5, 50 mM
NaCl, 20 mM Imidazole, 1.5 mM MgCl2) supplemented with 1 mM
phenylmethanesulfonyl ﬂuoride (PMSF) (#MB2001; Melford), 1 mg/ml lysozyme
and sonicated at 50% amplitude for 30 s in a 10 s on off cycle repeated thrice.
Extracts were cleared and puriﬁed using SP and Ni-NTA bead as described for
KIF1C-GFP above. Labelling of SNAPf26-PTPN21-FERM was performed on the
Ni-NTA beads by adding 3.5 µM SNAP-Surface Alexa Fluor 647 substrate and
incubating for 1 h at 4 °C. Beads were washed with bacterial Ni-NTA wash buffer
(50 mM sodium phosphate pH 7.5, 50 mM NaCl, 50 mM Imidazole and 10%
glycerol) to remove unbound dye and eluted with bacterial Ni-NTA elution buffer
(50 mM sodium phosphate pH 7.5, 50 mM NaCl, 150 mM Imidazole and 10%
glycerol). Labelling ratio was 0.4 for FERM-647. Puriﬁed proteins were ﬂash frozen
and stored in liquid nitrogen. For puriﬁcation of motor-GFP (i.e. KIF1C(1–349)-
GFP-6H), cells were lysed in Motor Lysis Buffer (50 mM Tris pH 7.4, 300 mM
NaCl, 20 mM Imidazole, 1 mM DTT, 1 mM MgCl2, 0.1 mM ATP, 0.05% Tween
20) supplemented with 2.5 mg/ml lysozyme and cleared of insoluble material by
centrifugation at 100,000 × g for 30 min at 4 °C in a Sorvall T865 rotor. Protein was
batch bound to 1.5 ml Ni-NTA agarose for 1.5 h at 4 °C before being washed with
450 ml lysis buffer followed by 200 ml washing buffer (lysis buffer with 40 mM
Imidazole). 0.5 CV elutions were collected using lysis buffer supplemented with
500 mM imidazole and 10% glycerol. To purify GST-stalk (i.e. GST-KIF1C
(612–922)) and GST control, bacterial cells were lysed in Tail Lysis Buffer (50 mM
Tris pH 7.4, 300 mM NaCl, 0.05% Tween 20, 1 mM DTT) supplemented with
2.5 mg/ml lysozyme, 1× cOmplete protease inhibitor and 2 mM PMSF. Lysate was
cleared by centrifugation at 100,000 × g for 30 min at 4 °C in a Sorvall T865 rotor.
Cleared lysate was bound to 1.5 ml SuperGlu GSH resin (#SuperGluA, Generon)
for 1.5 h at 4 °C, loaded into a column and washed with 450 ml lysis buffer,
followed by 250 ml Tail Wash Buffer (50 mM Tris pH 7.4, 500 mM NaCl, 0.05%
Tween 20, 1 mM DTT). Elutions of 0.5 CV were collected using lysis buffer
supplemented with 20 mM reduced glutathione and 10% glycerol. Puriﬁed proteins
were ﬂash frozen and stored in liquid nitrogen.
Hydrodynamic analysis. Size exclusion chromatography was carried out using
Superdex 16/60 200 pg (#28989335, GE Healthcare) column on an AKTApuriﬁer10
FPLC controlled by UNICORN 5.11 (GE Healthcare). The column was equili-
brated with the SEC Buffer (35 mM sodium phosphate pH 7.5, 150 mM NaCl,
1.5 mM MgCl2). Two hundred microlitres of ~0.5 mg/ml KIF1C-GFP or KIF1C-
Flag was injected into the column and 0.5 ml fractions were collected using the
fraction collector. GFP ﬂuorescence in the fractions was measured using Nanodrop
3300 Fluorospectrometer (Thermo Scientiﬁc) to determine peak positions. One
hundred microlitres of 5 mg/ml standard proteins were injected individually. The
Stokes radius for the standard proteins used were as follows thyroglobulin (#T9145,
Sigma) 8.5 nm50, apoferritin (#A3660, Sigma) 6.1 nm51, catalase (#C9322, Sigma)
5.2 nm52, bovine serum albumin (#A7906, Sigma) 3.48 nm53. Log Rs vs. (elution
volume-void volume) for standard proteins was plotted and stokes radius Rs for
KIF1C was determined from the slope of the line, y= (−0.014 ± 0.002) ×x + (0.97
± 0.04). Three independent repeats for KIF1C-GFP were carried out at 500 mM
NaCl and two at 150 mM NaCl. KIF1C-Flag was carried out once at 150 mM NaCl.
Five millimetres of 10–40% vol/vol glycerol gradients were made using the
Gradient master (#108, Biocomp) in 35 mM sodium phosphate pH 7.5, 1.5 mM
MgCl2, 0.1 mM ATP, 1 mM EGTA at different NaCl concentration (50, 150, 250,
350, 500 mM NaCl). One hundred microlitres of ~0.25 mg/ml KIF1C-GFP or
KIF1C-Flag was loaded on top of the gradient and the samples were centrifuged at
364,496 × g in SW55Ti (Beckman Coulter) for 16 h at 4 °C. Gradients were
fractionated by carefully pipetting 200 µl aliquots from the top. Absorbance at
280 nm was measured in Nanodrop 2000c Spectrophotometer and ﬂuorescence
using a Nanodrop 3300 Fluorospectrometer (Thermo Scientiﬁc) to determine peak
positions. One hundred microlitres of 5 mg/ml standard proteins were loaded
individually on separate gradients. The samples were processed for SDS-PAGE and
immunoblotting with anti-KIF1C primary (1:4000, #AKIN11, Lot 011,
Cytoskeleton) and anti-rabbit IgG HRP conjugate secondary (1:4000, #W401B, Lot
237671, Promega) antibodies. The sedimentation coefﬁcient of standard proteins
were: apoferritin 17.6S54, catalase 11.3S52, glucose oxidase (#G7141, Sigma) 8S55,
bovine serum albumin 4.6S53. Sedimentation coefﬁcient vs. elution volume for
standard proteins was plotted and sedimentation coefﬁcient for KIF1C at different
salt concentration was calculated from the slope of the line, y= (5.66 ± 0.49)*x*
−(3.92 ± 1.31). Independent repeats for KIF1C-GFP were carried out thrice
(500 mM NaCl and 50 mM NaCl), twice (150 and 250 mM) and once (350 mM),
respectively. KIF1C-Flag was carried out twice at 150 mM NaCl.
The molecular weight was calculated from stokes radius and sedimentation
coefﬁcient using equation Mr= 4205 ×RS × S as described in ref. 56. The frictional
coefﬁcient was calculated from the following formula, ƒ/ƒmin= Smax/S with Smax=
0.00361·M2/3 (ref. 56) using M= 308,000 Da for KIF1C-GFP dimer and S is the
sedimentation coefﬁcient determined from glycerol gradient centrifugation.
Crosslinking mass spectrometry. Two cross-linkers, BS3 (bis (sulpho-succini-
midyl) suberate) (#21580, Thermo Scientiﬁc) and EDC (1-ethyl-3-(3-dimethyla-
minopropyl) carbodiimide) (#22980, Thermo Scientiﬁc) were used to analyse
protein interactions using crosslink mass spectrometry. Five millimolar of cross-
linker was freshly prepared in MilliQ water and was mixed in the ratio of 1:2 with
the protein(s) of interest by pipetting. KIF1C-GFP concentration was 1 µM when
crosslinked alone. For crosslinking in the presence of PTPN21-FERM, both pro-
teins were at 0.5 µM. Final concentration NaCl in the crosslinking reaction was 150
mM or increased to 500 mM for high salt sample. For EDC crosslinking, 3 nM N-
hydroxysulfosuccinimide (#24510, Thermo Scientiﬁc) was added to the reaction
with EDC to improve efﬁciency of the crosslinking. The reaction was incubated
shaking at 400 r.p.m. for an hour at room temperature and then quenched with 50
mM Tris-HCl pH 7.5. Next, the protein was diluted in equal volume of 50 mM
ammonium bicarbonate (#A6141, Sigma) and reduced using 1 mM DTT
(#MB1015, Melford) for 60 min at room temperature. The sample was then
alkylated with 5.5 mM iodoacetamide (#I6709, Sigma) for 20 min in the dark at
room temperature and digested using 1 µg trypsin (sequencing grade; #V5111,
Promega) per 100 µg of protein overnight at 37 °C. The crosslinked peptides were
desalted using C18 stage tips. Twenty microlitre samples were then analysed by
nano LC-ESI-MS/MS using UltiMate® 3000 HPLC series using Nano Series™
Standard Columns for separation. A linear gradient from 4% to 35% solvent B
(0.1% formic acid in acetonitrile) was applied over 30 min, followed by a step
change 35–70% solvent B for 20 min and 70 to 90% solvent B for 30 min. Peptides
were directly eluted (~300 nl/min) via a Triversa Nanomate nanospray source into
a Orbitrap Fusion mass spectrometer (Thermo Scientiﬁc). Positive ion survey scans
of peptide precursors from 375 to 1500m/z were performed at 120 K resolution
(at 200m/z) with automatic gain control 4 × 105. Precursor ions with charge state
2–7 were isolated and subjected to HCD fragmentation in the Orbitrap at 30 K
resolution or the Ion trap at 120 K. MS/MS analysis was performed using collision
energy of 33%, automatic gain control 1 × 104 and max injection time of 200 ms.
The dynamic exclusion duration was set to 40 s with a 10 ppm tolerance for the
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selected precursor and its isotopes. Monoisotopic precursor selection was turned
on. The instrument was run in top speed mode with 2 s cycles.
Raw data ﬁles were converted to.mgf format using the ProteoWizard msconvert
toolkit57. Sequences are visualised using Scaffold (Proteome software) for
percentage coverage and purity followed by analysis using StavroX22. Crosslinked
peptides were identiﬁed using the StavroX software with appropriately deﬁned
parameters for the crosslinker used. A crosslinked peptide was considered as valid
if it passed the 5% false discovery rate (FDR) cut-off along with a StavroX score of
at least 100, which is based on: (i) the presence of ion series fragmentation for both
peptides, speciﬁcally those fragment ions that include the crosslinker and the
attached second peptide, (ii) the proximity of observed fragmentation ion mass to
expected fragment ion mass, (iii) number of ion fragments for b or y ions in
the a peptide, (iv) number of unidentiﬁed high intensity signals in the spectra. The
MS/MS spectra were also manually inspected and only those crosslinks were
accepted for which fragmentation ions were observed for both peptides and three
or more fragments for b or y ions in the alpha peptide were required to match. Any
crosslinks of continuous peptides, which could indicate intradimer interactions,
were rejected as these could not be distinguished from partially cleaved peptides
that have been modiﬁed by the crosslinker. Once a signiﬁcant crosslink was
identiﬁed in at least one sample, we used the information on retention time and
mass of the precursor ion to verify the presence of the crosslinked peptide in other
samples.
Label-free quantiﬁcation of crosslinked precursor ions and unmodiﬁed peptides
was done using MaxQuant (V1.5.5.1). The LFQ module calculates the integrated
peak area of the precursor ion based on a retention time window of 4 min and ppm
error window of 10 ppm to quantify the presence and absence of a precursor ion of
interest in different mass spectrometry output ﬁles. LFQ intensity data for each
sample were normalised to the sum of unmodiﬁed and modiﬁed peptides
containing LKEGANINK. BS3 experiments were repeated 3–5 times and EDC
experiments 2–3 times for each sample.
Microscale thermophoresis. GST-stalk was rebuffered into MST buffer (50 mM
Tris pH 7.4, 150 mM NaCl, 10 mM MgCl2, 0.05 % Tween- 20) using Zeba Spin
Desalting Columns (Thermo Scientiﬁc). The resulting 37 µM stock solution was
used to prepare a twofold dilution series. Motor-GFP was diluted in MST buffer
to a ﬁnal concentration of 250 nM, 2 µl of which was mixed with 8 µl of each GST-
stalk dilution. Capillaries were ﬁlled with 10 µl protein mix and thermophoresis
performed in a Monolith NT.115 (Nanotemper) using 30% Nano Blue detection
and 40% MST power at 25 °C. The experiment was repeated three times. Traces
were analysed in 0.5 and 1.5 s heating window and the Kd model was ﬁtted using
MO.Afﬁnity Analysis software (Nanotemper).
BioID protein interaction analysis. For each BioID experiment, three 14.5 cm
dishes of RPE1 cells were grown, and each was transfected at 90% conﬂuency with
20 µg DNA diluted in 1 ml Optimem (#31985062, Fisher) with 60 µg poly-
ethylenimine (PEI, #408727, Sigma). After 24 h, media was replaced and supple-
mented with 50 µM biotin (#8.51209, Sigma). After a further 12 h, cells were
harvested by trypsinisation, washed with PBS and lysed in RIPA buffer (#9806S,
New England Biolabs) supplemented with 250 U of benzonase (#E1014, Sigma).
Lysate was cleared by centrifugation in a tabletop centrifuge at 20,238 ×g for 30 min
at 4 °C (#5417R, Eppendorf), and bound to 50 µl streptavidin-coated Dynabeads
(#65601, Invitrogen) for 1.5 h, washing away unbound proteins with 3 × 1ml of
PBS. Beads were resuspended in 45 µl 50 mM ammonium bicarbonate, reduced by
adjusting to a ﬁnal concentration of 10 mM TCEP, and subsequently alkylated
by adjusting to 40 mM chloroacetamide (#C0267, Sigma), incubating at 70 °C for
5 min. Proteins were digested off of the beads with 0.5 µg Trypsin (#V5111, Pro-
mega) at 37 °C overnight. Peptides were separated from beads by ﬁltration through
a 0.22 µm tube ﬁlter (#CLS8169, Sigma) and desalted using C18 stage tips. Twenty
microlitres of peptides were then analysed by nano LC-ESI-MS/MS in an Ultimate
3000/Orbitrap Fusion. Hits were automatically identiﬁed, thresholded and viewed
in Scaffolds software. We performed three independent experiments of which one
had three technical replicated. Statistical analysis was performed in Scaffolds using
a Fisher’s exact test with Benjamini–Hochberg correction, which resulted in a
signiﬁcance threshold of 0.0019 for a 5% FDR.
Cell culture. A7r5 rat vascular smooth muscle cells (ATCC, #CRL-1444) were
grown and maintained in low-glucose (1000 mg/l) Dulbecco’s modiﬁed Eagle’s
medium (DMEM), supplemented with 10% foetal bovine serum at 37 °C and 5%
CO2. For siRNA oligonucleotide transfection, HiPerFect (#301704 Qiagen) was
used according to the manufacturer’s protocol. Rescue DNA plasmids were
transfected using Fugene6 (#E2691, Promega) 24 h after siRNA transfection, cells
seeded onto 16 mm glass coverslips (#1232–3148 Fisherbrand) coated for 24 h with
10 µg/ml ﬁbronectin (#F1141 Sigma) and analysed 72 h1 after siRNA transfection.
Podosome formation was stimulated in A7r5 cells by treatment with 5 µM PDBu
(Phorbol 12,13-dibutyrate; #P1269 Sigma) for 1 h. For inhibition of Myosin IIA
contractile activity, Y27632 Rock inhibitor (#Y0503 Sigma) or Blebbistatin (#B0560
Sigma) were added at various concentrations as indicated in ﬁgure labels at the
same time as PDBu. DMSO (#D2438, Sigma) was used as a negative control.
The RPE1 α5-integrin-GFP stable cell line was established as follows: hTERT
RPE1 cells (Clontech) were transfected with pα5-integrin-GFP44 followed by
selection with 500 µg/ml Geneticin (#G8168 Sigma) and expansion of single
colonies that were screened using ﬂuorescence microscopy. The α5-integrin-GFP
cell line was grown in RPE1 growth medium (DMEM/Nutrient F-12 Ham (#D6421
Sigma), 10% FBS (Sigma), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma),
100 µg/ml streptomycin (Sigma) and 2.3 g/l sodium bicarbonate (#S8761 Sigma))
supplemented with 500 µg/ml Geneticin (Sigma). RPE1 cells were transfected with
siRNA using Oligofectamine (#12252011 Invitrogen), with DNA using Fugene6
and analysed 72 h after siRNA transfection.
Hippocampi were dissected from P1 or P2 mice brains and incubated with
papain (#P4762 Sigma) in cold dissection medium (Earl’s buffered salt solution
EBSS (#14155 Gibco), 10 mM HEPES (#H0887 Sigma) and 100 U/ml pen-strep)
for 15 min at 37 °C. After digestion, the hippocampi were spun at 300 × g for 2 min
in a swing out 5804 S-4-72 rotor, washed (10 ml) and resuspended (1 ml) in plating
media (modiﬁed eagle medium (MEM) (#51200–046 Gibco) supplemented with
100 U/ml pen-strep, 1% N2 (#17502-048, Gibco), 10% horse serum (#26050-039,
Gibco), 20 mM glucose, 1 mM sodium pyruvate (#S8636, Sigma) and 25 mM
HEPES). Cells were plated on laminin (#L2020, Sigma)/poly-D-lysine (#P0899,
Sigma)-coated coverslips and fed by replacing 50% of the medium with plating
medium according to Granseth et al.58. Neurons were transfected at DIV4 or DIV5
with lipofectamine 2000 (#11668027, Thermo Scientiﬁc) according to the
manufacturer’s protocol and imaged the next day.
Fixed cell imaging. Cells were ﬁxed for 15 min with 4% paraformaldehyde
(#15714, Electron Microscopy Sciences) diluted in Cytoskeleton Buffer (10 mM
MES pH 6.1, 138 mM KCl, 3 mM MgCl2, 2 mM EGTA, 0.32M sucrose). Fixed cells
were incubated for 2 min with 0.1% Triton X-100 (#T8787, Fisher Scientiﬁc)
diluted in PBS. Coverslips were then washed with PBS and incubated for 30 min
with 0.5% BSA diluted in PBS/0.1%Tween (PBST). Cells were stained for an hour
at room temperature or overnight at 4 °C with 1:100 anti-cortactin 4F11, (#05-180,
Lot 2290226, Millipore) primary antibodies diluted in 0.5% BSA-PBST solution.
Coverslips were washed with PBST and incubated for 45 min at room temperature
with 1:300 anti-mouse IgG 647 conjugate (#A31571, Lot 47735A, Molecular
Probes) secondary antibodies and 1:1000 Acti-stain 555 phalloidin (#PHDH1-A,
Cytoskeleton) diluted in 0.5% BSA in PBST. Nuclei were stained with 5 µg/ml
DAPI (#D9542, Sigma) for 1 min and coverslips washed with PBST prior to
mounting on glass slides with Vectashield (#H1000, Vector Laboratories).
Cells were imaged using a Deltavision Elite Wide-ﬁeld microscope and Z-stacks
of individual cells were acquired using a ×40 NA 1.49 objective and a Z-spacing
of 0.2 µm.
To determine the number of podosomes formed in each cell, images of the
cortactin channel were ﬁrst transformed in a Z-projection. Z-projection images
were then segmented using the ImageProAnalyzer 7 software by applying a
threshold and a minimal size ﬁlter of 16 pixels (2.58 µm2). Individual objects
identiﬁed in the cortactin Z-projection were then visually compared to the actin
channel to conﬁrm they are podosomes, removed if the cortactin staining did
not coincide with an actin spot and podosome clusters were split into individual
podosomes. All experiments were repeated three times with 30 cells being analysed
for each condition in each experiment.
Live cell imaging. Live cells were imaged using a ×60 oil NA 1.4 objective on an
Olympus Deltavision microscope (Applied Precision, LLC) equipped with eGFP,
mCherry ﬁlter sets and a CoolSNAP HQ2 camera (Roper Scientiﬁc) under the
control of SoftWorx (Applied Precision). The environment was maintained at
37 °C and 5% CO2 using a stage-top incubator (Tokai Hit) and a weather station
(Precision control).
RPE1 α5-integrin-GFP cells were seeded 24 h before imaging into quadrant
glass-bottom dishes (#627975, Greiner) coated with 10 µg/ml Fibronectin. Cells
with tails were selected and the mid region of the tail was bleached using the 488
nm laser. Vesicle movement was imaged for 200 time points at 0.7–1.0 s per frame.
α5-integrin-GFP trafﬁcking was analysed using ImageJ. Kymographs were
generated from parallel 21 pixel wide lines covering the area of the tail. Vesicle
movement was extracted manually from all kymographs using the segmented
line tool. Vesicles moving less than a total of 1.5 µm over the period of imaging
were classiﬁed as stationary.
Primary mouse hippocampal neurons transfected with pNPY-RFP and either
pFlag (as control) or pFERM and imaged at DIV5 or DIV6. Images were acquired
with 500 ms exposure every 1.5 s for 160 s. The frequency of NPY-positive vesicles
passing through a location in the neurite in anterograde and retrograde direction
was determined manually from kymographs.
RPE1 cells co-transfected with pKIF1C-mCherry and either pKIF1C-GFP,
pKIF1CΔCC3-GFP or pKIF1CΔS-GFP were imaged 36 h post transfection. Images
were acquired with 500 ms exposure in the eGFP channel and 1 s exposure in the
mCherry channel. To determine the ratio of enrichment at the tail, a region of
interest was drawn manually surrounding the accumulation observed and the
mean intensity was measured at the tail, in the cytoplasm near the nucleus and
the image background outside the cell in both channels. The ratio of KIF1C
enrichment at the tail was calculated as Itail−Ibackground /Icytoplasm−Ibackground for
GFP vs. mCherry channel.
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Co-immunoprecipitation. HEK293 cells (Agilent, #240073) were seeded at a
density of 1.5 × 106 cells onto one 10 cm dish 24 h before transfection with
pKIF1CRIP1-2Flag, pKIF1CΔS-GFP or pGFP-4Flag and either pHook3-GFP or pHA-
PTPN21RIP. Two micrograms of DNA was mixed with 6 µl 1 mg/ml PEI (Sigma) in
200 µl PBS, incubated for 15 min and then added onto cells for transfection.
Transiently transfected cells were collected 20–24 h after transfection by decanting
the media and washing the cells off the dish with 5 ml ice cold 1× PBS. Cells were
collected by centrifugation at 300 × g for 3 min and washed twice with 1× PBS. The
cell pellets were lysed in 130 μl of dynein lysis buffer (DLB: 30 mM HEPES, pH 7.4;
50 mM KOAc; 2 mM MgOAc; 1 mM EGTA, pH 7.5; 10% glycerol) supplemented
with 1 mM DTT, 0.2% Triton X-100, 1× protease inhibitor cocktail (Expedion) by
sonication in the ice- water bath of the Bioruptor (Diagenode) at medium setting
for 5 min (30 s on, 30 s off cycle). Lysates were cleared at maximum speed in
Eppendorf microcentrifuge (5417 R) at 4 °C for 15 min. For each reaction, 10 μl of
Dynabeads Protein G (Invitrogen 100.03D) were incubated with 1 µg anti-Flag
antibodies (#F3165, Lot 058K6113, Sigma) for 20 min at room temperature and
then washed three times with 100 µl DLB. One hundred and twenty microlitres of
cell lysate was added to the beads and incubated for 25 min at 4 °C. The beads were
washed seven times with 1 ml DLB. To recover bound proteins, beads were
resuspended in 35 μl 1× Laemmli buffer and incubated at 95 °C for 2 min. Samples
were separated over 10% polyacrylamide gels followed by immunoblotting. Wes-
tern blots were detected using 1:4000 anti-KIF1C (#AKIN11, Lot 011, Cytoskeleton
Inc.), 1:5000 anti-HA (C29F4) (#3724 S, Lot 9, Cell Signalling Technologies) and
1:3000 anti-Hook3 (#15457-1-AP, Proteintech) as primary antibodies and anti-
rabbit-HRP (#W401B, Lot 237671, Promega). Detection with SuperSignal West
Pico Plus substrate (Pierce) was followed by imaging chemiluminescence in G-Box
(Syngene) or using blue-sensitive ﬁlm.
Single-molecule motility and binding assays. Microtubules were assembled from
8 μl of 3.4 mg/ml unlabelled pig tubulin, 0.2 μl of 1 mg/ml HiLyte Fluor 670 tubulin
(#TL670M, Cytoskeleton) and 0.5 μl of 0.5 mg/ml biotin tubulin (#T333P, Cytos-
keleton) in MRB80 (80 mM PIPES pH 6.8, 4 mM MgCl2, 1 mM EGTA, 1 mM
DTT). The mixture was incubated on ice for 5 min before adding 8.5 μl of poly-
merisation buffer (2× BRB80 buffer plus 20% (v/v) DMSO and 2mM MgGTP).
Microtubules were polymerised at 37 °C for 30–60 min. The sample was diluted
with 100 μl MT-buffer (MRB80 plus 30 μM paclitaxel). Unincorporated tubulin
was removed by pelleting microtubules at 20,238 × g for 8.5 min at room tem-
perature, washing the pellet with 100 μl MT-buffer and re-pelleting as before. The
microtubule pellet was resuspended in 50 μl of MT-buffer and stored at RT covered
from light for at least half a day (maximum 3 days) before use.
Coverslips (22 × 22) were cleaned by incubating in 2.3 M hydrochloric acid
overnight at 60 °C. The next day, coverslips were washed with Millipore water and
sonicated at 60 °C for 5 min. The wash cycle was repeated ﬁve times. The coverslips
were dried using a Spin Clean (Technical video) and plasma cleaned using
Henniker plasma clean (HPT-200) for 3 min. Flow chambers were made using
clean glass slides (Menzel Gläser Superfrost Plus, Thermo Scientiﬁc) and double-
sided sticky tape (Scotch 3M) by placing the cleaned coverslip on the sticky tape
creating a 100 µm deep ﬂow chamber. The surface was coated with (0.2 mg/ml)
PLL(20)-g[3.5]-PEG(2)/PEG(3.4)-Biotin (50%) (#PLL(20)-g[3.5]-PEG(2)/PEGbi,
Susos AG). Biotin-647-microtubules were attached to this surface with streptavidin
(0.625 mg/ml) (#S4762 Sigma) and the surface was blocked with κ-casein
(1 mg/ml) (#C0406 Sigma).
KIF1C-GFP, PTPN21-FERM and Ezrin-FERM were pre-spun at 100,000 × g for
10 min in an Airfuge (Beckman Coulter). Six hundred picomolar KIF1C-GFP was
incubated with either Ni-NTA elution buffer or 125 nM PTPN21-FERM or 125 nM
Ezrin-FERM for 15 min at room temperature. The complex was then diluted in the
motility mix (MRB80 supplemented with 1 mM ATP, 5 mM phosphocreatine
(#P7936, Sigma), 7 U/ml creatine phosphokinase (#C3755 Sigma), 0.2 mg/ml
catalase, 0.4 mg/ml glucose oxidase, 4 mM DTT, 50 mM glucose (#G8270, Sigma),
25 mM KCl, 100 µM taxol, 0.2 mg/ml κ-casein) and ﬂown into the chamber.
Experiments with KIF1CΔCC3-GFP and KIF1CΔS-GFP were performed in the
same way. To verify that comparable amount of motors were added to the assay,
the ﬂuorescence intensity of KIF1C-GFP, KIF1CΔCC3-GFP and KIF1CΔS-GFP
solutions were measured prior to incubation and ﬂowing into the chamber. KIF1C
and Hook3 experiments were prepared using 8 nM Kif1C-GFP and 25 nM Hook3-
647 in the same motility mix, but replaced MRB80 with TIRF assay buffer (30 mM
HEPES-KOH pH 7.2, 5 mM MgSO4, 1 mM EGTA, 1 mM DTT) as this has
previously been described for Hook3-based dynein motility28.
Chambers were observed on an Olympus TIRF system using a ×100 NA 1.49
objective, 488 and 640 nm laser lines, an ImageEM emCCD camera (Hamamatsu
Photonics) under the control of xCellence software (Olympus), an environmental
chamber maintained at 25 °C (Okolab, Ottaviano, Italy).
For single-molecule motility assays with KIF1C-GFP, KIF1CΔCC3-GFP,
KIF1CΔS-GFP and FERM domains images were acquired at 30% laser power every
100 ms for 180 s at an exposure of 60 ms for 488 nm laser line, whereas for
experiments with KIF1C-GFP and Hook3, images were acquired at 280 ms for 250
s at an exposure of 150 ms for 488 nm (30% laser power) and 60 ms for 647 nm
(10% laser power) laser lines.
For cotransport assay, KIF1C-GFP or KIF1CΔS-GFP was incubated with either
Hook3-SNAPf647 or 647SNAPf-FERM at 20× the ﬁnal concentration before being
diluted into imaging buffer. Images were taken once every 275 ms using 50 ms
exposure with a 647 nm laser line followed by 150 ms exposure with a 488 nm laser
line, using laser powers of 18% and 21%, respectively.
Images were analysed by generating kymographs from each microtubule using the
ImageJ plugin by Arne Seitz (https://biop.epﬂ.ch/TOOL_KYMOGRAPH.html) and
manually identifying runs by scoring the kymographs for moving and static motors.
The speed and run length was calculated from the length and slope of each run using
a custom ImageJ macro. Blind analysis was carried out to determine landing rates
and frequency of running motors in all data sets.
For TIRF-based microtubule binding assays, 80 nM motor-GFP was mixed with
either 20 µM GST-stalk or the same amount of GST as a control. These mixtures
were diluted 1:20 into motility mix as described for KIF1C-Hook3 single-molecule
experiments, yielding a ﬁnal protein concentration of 4 nM motor domain to 1 µM
tail or GST control. The motility mixture was ﬂown into chambers prepared with
unlabelled GDP-taxol microtubules, and microtubule intensities in ten random
ﬁelds-of-view were captured with an exposure time of 400 ms and 21.4% 488 laser
power. Control and experimental chambers were prepared in parallel, and we
alternated which chamber was imaged ﬁrst to account for time effects. For analysis,
microtubules were traced by hand with a line ROI in ImageJ, and the mean
intensity was taken. A region close to the microtubule was selected as the local
background, and subtracted from the mean to generate a local-background
corrected intensity.
Bleach step analysis. A ﬂow chamber was prepared as described above with
biotin-647-microtubules immobilised on the coverslip. Six hundred picomolar
KIF1C-GFP was ﬂown into a chamber with MRB80, 1 mM AMP-PNP, 100 µM
taxol and 0.2 mg/ml κ-casein. Images were acquired every 500 ms for 600 s at an
exposure of 400 ms using the 488 nm laser line at 50% laser power. Images were
analysed using the Plot Proﬁle function in ImageJ for each individual spot and
manually counting bleach steps. A mixed binomial distribution for dimers and
tetramers of KIF1C was ﬁtted to the data using Eq. (1), where P(k) is the prob-
ability to ﬁnd k bleach steps, p is the fraction of active GFP and x is the fraction of
tetramers.
P kð Þ ¼ 2!
k! 2 kð Þ! ´ p
k 1 pð Þ2k
 
´ 1 xð Þ þ 4!
k! 4 kð Þ! ´ p
k 1 pð Þ4k
 
´ xð Þ:
ð1Þ
Statistical analysis and ﬁgure preparation. Statistical data analyses and graphs
were generated using Origin Pro 8.5 (OriginLab), python’s Matplotlib and Scipy
packages or R. Box plots show quartiles with whiskers indicating 10% and 90% of
data as well as the mean indicated with a circle. All statistical signiﬁcance analyses
were carried out using two-tailed two-sample t-tests assuming equal variance
(referred to a t-test is legends), Mann–Whitney U-test, ANOVA with post hoc
Tukey, or Kolmogorov–Smirnov test. Where necessary, p-values were adjusted for
multiple comparisons using Bonferroni or Holm–Šídák corrections. Figures were
prepared by adjusting min/max and applying and inverting look up tables using
ImageJ and assembled using Adobe Illustrator.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the ﬁndings of this manuscript are available from the corresponding
author upon reasonable request. A reporting summary for this Article is available as
a Supplementary Information ﬁle. The source data underlying Figs. 1a, 1e, 3c, 3d, 3f, 3g,
3h, 4c, 4d, 4f, 5d, 5e, 6c, 6j, 6k and 7c, 7f and Supplementary Figs 2e and 6 are provided
as a Source Data ﬁle. Our BioID mass spectrometry data are provided in Supplementary
Data 1. The crosslinking mass spectrometry data have been deposited to the
ProteomeXchange Consortium via the PRIDE59 partner repository with the dataset
identiﬁer PXD013939.
Code availability
Custom ImageJ macros will be available at the CMCB Github (https://github.com/cmcb-
warwick) and on our website (http://mechanochemistry.org/Straube/#tab=soft) upon
publication.
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